You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
- 2. ‘You pray that you got the drug.' Ailing couple gambles on trial for COVID-19 cure
- 3. A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors
- 4. First-In-Human Study of EOS884448 in Participants With Advanced Cancers.
- 5. NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
- 6. A smart bra for detecting early-stage breast cancer
- 7. European Commission Approves Takeda's ALUNBRIG (brigatinib) as a First-Line Treatment for ALK+ NSCLC
- 8. Servier agrees to buy Symphogen to swell its cancer pipeline
- 9. INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
- 10. Scientist proposes clinical trials with low-dose rapamycin to protect elderly from COVID-19
Last updated at 10:02 GMT
Hot News Makers
Health/Pharma Companies
-
38315.94
-
27005.44
-
25608.64
-
21592.02
-
13126.77
-
13042.99
-
11826.83
-
10650.51
-
10617.81
-
10492.66
Last updated at 9:10 GMT
© Copyright 2020 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK